Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR‐103 target site

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Human Mutation

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/humu.22159PMID 22753153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS

  2011cited by this paper
• miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

  2011cited by this paper
• Morphological predictors of BRCA1 germline mutations in young women with breast cancer

  2011influential reference
• Role of RNA binding protein HuR in ductal carcinoma in situ of the breast

  2011cited by this paper
• Rare BRCA1 haplotypes including 3’UTR SNPs associated with breast cancer risk

  2011influential reference
• Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers

  2011cited by this paper
• Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry

  2011cited by this paper
• Desperately seeking microRNA targets

  2010cited by this paper
• Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

  2010cited by this paper
• The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

  2010cited by this paper
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cited by this paper
• Genetic susceptibility to breast cancer

  2010cited by this paper
• An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.

  2010cited by this paper
• A MicroRNA targeting dicer for metastasis control.

  2010cited by this paper
• BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

  2009cited by this paper
• A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

  2009cited by this paper
• SNPs in ultraconserved elements and familial breast cancer risk.

  2009cited by this paper
• SNPs in ultraconserved elements and familial breast cancer risk.

  2009cited by this paper
• Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.

  2009cited by this paper
• Role of 5′‐ and 3′‐untranslated regions of mRNAs in human diseases

  2009cited by this paper
• A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.

  2008cited by this paper
• Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.

  2008cited by this paper
• Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

  2008cited by this paper
• Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk.

  2008cited by this paper
• Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.

  2007cited by this paper
• Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer

  2007cited by this paper
• Prognostic Role of HuR in Hereditary Breast Cancer

  2007cited by this paper
• Regulation of BRCA1 messenger RNA stability in human epithelial cell lines and during cell cycle progression

  2007cited by this paper
• A common coding variant in CASP8 is associated with breast cancer risk

  2007cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007influential reference
• A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

  2006cited by this paper
• A guide through present computational approaches for the identification of mammalian microRNA targets

  2006cited by this paper
• Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

  2005cited by this paper
• An optimized isolation and labeling platform for accurate microRNA expression profiling.

  2005cited by this paper
• Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families

  2005cited by this paper
• Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes.

  2005cited by this paper
• Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome

  2005cited by this paper
• The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer

  2004cited by this paper
• The RNA-binding Protein HuR Regulates the Expression of Cyclooxygenase-2*

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

  2003cited by this paper
• Corrigendum: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

  2002cited by this paper
• ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Clinical Chemistry 47:7 1183–1189 (2001) Molecular Diagnostics and Genetics In-Tube DNA Methylation Profiling by Fluorescence Melting Curve Analysis

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

  2000cited by this paper
• Breast cancer in Australian women under the age of 40

  1998cited by this paper
• The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations

  1998cited by this paper
• mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end.

  1997influential reference
• AU-rich elements: characterization and importance in mRNA degradation.

  1995cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• A versatile in vivo and in vitro eukaryotic expression vector for protein engineering

  1988influential reference

• Genetic variants in oncogenic miRNA and 3′ untranslated region of tumor suppressor genes: emerging insight into cancer genetics

  2025cites this paper
• Spectrum and genotyping strategies of "dark" genetic matter in germline susceptibility genes of tumour syndromes.

  2024cites this paper
• BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil

  2023cites this paper
• Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study

  2023cites this paper
• Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions

  2021cites this paper
• Genetic variations in 3´UTRs of SMUG1 and NEIL2 genes modulate breast cancer risk, survival and therapy response.

  2021cites this paper
• Bioinformatics Analysis Revealed Novel 3′UTR Variants Associated with Intellectual Disability

  2020cites this paper
• Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene

  2020cites this paper
• Characterization and in silico analyses of the BRCA1/2 variants identified in individuals with personal and/or family history of BRCA-related cancers.

  2020cites this paper
• Genetic Variants in the 3’UTR of BRCA1 and BRCA2 Genes and Their Putative Effects on the microRNA Mechanism in Hereditary Breast and Ovarian Cancer

  2020cites this paper
• MicroRNA-103a-3p potentiates chemoresistance to cisplatin in non-small cell lung carcinoma by targeting neurofibromatosis 1

  2020cites this paper
• Bioinformatics Analysis Revealed Novel 3 (cid:48) UTR Variants Associated with Intellectual Disability

  2020cites this paper
• Genotyping of Exon 2 BRCA1for Breast Cancer in Iraqi Women by Sanger Sequencing

  2020cites this paper
• Alternative splicing regulation by GWAS risk loci for breast cancer

  2019cites this paper
• AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke.

  2019cites this paper
• Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma.

  2019cites this paper
• Functional coding and non-coding variants in human BRCA1 gene and their use in genetic screening

  2019cites this paper
• Mis‐splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays

  2019cites this paper
• Allele-specific miRNA-binding analysis identifies candidate target genes for breast cancer risk

  2019cites this paper
• The 3’-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and GSD-Ia risk

  2019cites this paper
• Caution: Plasmid DNA topology affects luciferase assay reproducibility and outcomes.

  2019cites this paper
• miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro

  2018cites this paper
• Identification of Single Nucleotide Non-coding Driver Mutations in Cancer

  2018cites this paper
• A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population

  2018cites this paper
• Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants

  2018cites this paper
• BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

  2018cites this paper
• Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition

  2018cites this paper
• A master regulatory network restoring brain glutamate homeostasis is coordinately activated in stroke

  2018cites this paper
• AGO CLIP reveals an activated network for acute regulation of brain glutamate homeostasis after ischemic stroke

  2018cites this paper
• The prodigious network of chromosome 17 miRNAs regulating cancer genes that influence the hallmarks of cancer.

  2017cites this paper
• 3'-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and Glycogen Storage Disease type-Ia risk.

  2017cites this paper
• Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18

  2017cites this paper
• MicroRNA-103 regulates tumorigenesis in colorectal cancer by targeting ZO-1

  2017cites this paper
• Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study

  2016cites this paper
• microRNA editing in seed region aligns with cellular changes in hypoxic conditions

  2016cites this paper
• Noncoding RNA: Current Deep Sequencing Data Analysis Approaches and Challenges

  2016cites this paper
• Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers

  2016cites this paper
• MicroRNAs 103 and 107 link type 2 diabetes and post-menopausal breast cancer

  2016cites this paper
• Functional SNP in 3′‐UTR MicroRNA‐Binding Site of ZNF350 Confers Risk for Age‐Related Cataract

  2016cites this paper
• rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility

  2016cites this paper
• BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.

  2015cites this paper
• Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicity

  2015cites this paper
• In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci

  2015cites this paper
• VHL and HIF in Clear Cell Renal Cell Carcinoma: Molecular Abnormalities and Potential Clinical Applications

  2015cites this paper
• Epigenetics of BRCA-1–Related Breast Tumorigenesis and Dietary Prevention

  2014cites this paper
• An Investigation Into the Molecular Mechanisms and Genes Involved in Hypoxic Signalling Pathways in Neural Crest Derived Tumours

  2014cites this paper
• Inhibitor of apoptosis proteins as regulatory factors in the normal and inflamed airways.

  2014cites this paper
• Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations

  2014cites this paper
• The contribution of genetic susceptibility to breast cancer

  2014influential citation
• Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.

  2014cites this paper
• MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2

  2014cites this paper
• gDNA enrichment by a transposase-based technology for NGS analysis of the whole sequence of BRCA1, BRCA2, and 9 genes involved in DNA damage repair.

  2014cites this paper
• Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

  2014cites this paper
• Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma

  2014cites this paper
• PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways

  2013cites this paper
• MiRNAs as Regulators of Tumour Suppressor Expression

  2013cites this paper
• Comparison of Mrna Splicing Assay Protocols across Multiple Laboratories: Recommendations for Best Practice in Standardized Clinical Testing on Behalf of the Enigma Consortium

  year unknowncites this paper